Spots Global Cancer Trial Database for ICG-Enabled Mapping of Ovarian Sentinel Lymph Nodes: A Feasibility Study
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Trial Identification
Brief Title: ICG-Enabled Mapping of Ovarian Sentinel Lymph Nodes: A Feasibility Study
Official Title: ICG-Enabled Mapping of Ovarian Sentinel Lymph Nodes: A Feasibility Study
Study ID: NCT04051502
Study Description
Brief Summary: The purpose of this study is to find out how well ovarian sentinel lymph nodes (SLNs) can be identified with indocyanine green (ICG) dye during risk-reducing ovarian surgery.
Detailed Description:
Eligibility
Minimum Age: 18 Years
Eligible Ages: ADULT, OLDER_ADULT
Sex: FEMALE
Healthy Volunteers: No
Locations
Memorial Sloan Kettering Basking Ridge (Consent only), Basking Ridge, New Jersey, United States
Memorial Sloan Kettering Monmouth (Consent only), Middletown, New Jersey, United States
Memorial Sloan Kettering Bergen (Consent only ), Montvale, New Jersey, United States
Memorial Sloan Kettering Commack (Consent only), Commack, New York, United States
Memorial Sloan Kettering Westchester (Consent only), Harrison, New York, United States
Memorial Sloan Kettering Cancer Center, New York, New York, United States
Memorial Sloan Kettering Nassau (Consent only), Uniondale, New York, United States
Contact Details
Name: Ginger Gardner, MD
Affiliation: Memorial Sloan Kettering Cancer Center
Role: PRINCIPAL_INVESTIGATOR
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
